Bing

The company's stock has declined steadily in 2015 ... also decreased slightly. Johnson & Johnson (NYSE: JNJ) is a large parent company that owns subsidiaries that research, develop, manufacture and sell various …
Investopedia · 8/26/2015
health care
As one of the country’s leading wealth managers, Richard Jennings has spent most of the past week reassuring clients that their investments will survive the current stock market turmoil. Founder of JNJ Financial …
Daily Mail · 8/29/2015
Stock markets
NEW YORK (TheStreet) -- Shares of Johnson & Johnson (JNJ - Get Report) were falling 1.46% to $98.81 Tuesday morning despite the health care company's positive second quarter results. Johnson & Johnson reported earnings of $1.71 a share for the …
The Street · 7/14/2015
This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible underperform ... Johnson & Johnson (NYSE:JNJ) follows with a loss of 2.25% and Akorn (NASDAQ:AKRX) rounds out the bottom five with a …
Financial News Network Online · ByRobert Cotter · 8/26/2015
The fifth-most heavily weighted stock on the DJIA has traded about 10% more shares than its daily average of 4.1 million. Johnson & Johnson (NYSE: JNJ) dipped to a new 52-week low of $81.79 this morning, down more than 14% from Friday’s close.
Market Watch · 8/24/2015
Johnson & Johnson (NYSE:JNJ) has agreed to sell its iconic sweetener product SPLENDA ... We estimate that Johnson & Johnson’s consumer business constitutes merely 2% of the company’s stock. The EBITDA margins are much lower than those …
Trefis · 8/27/2015
Splenda
listed shares of GlaxoSmithKline Plc (Other OTC: GLAXF - news) touchlowest in nearly 4 years at $39.37, Merck (Jakarta: 28586808.JK - news) & Co hitslowest in more than 2 years at $45.70, Johnson & Johnson (NYSE: JNJ - news) falls to 52-month low …
Yahoo News · 8/24/2015
Fueled by Gilead Sciences, Inc’s Hepatitis C Drugs, US Drug Spending Surged To $373.9 Billion In 2014 PUBLISHED: Apr 14, 2015 at 12:39 pm EST Data compiled by IMS shows that US spending on prescription drugs increased the most in 13 years …
bidnessetc.com · 2/19/2015
Johnson & Johnson (JNJ.N) on Tuesday said it was selling its widely used Splenda ... J&J shares fell 2.25 percent to $90.73 on the New York Stock Exchange on Tuesday. Tate & Lyle shares rose almost 0.9 percent in London.
Reuters · ByRansdell Pierson · 8/26/2015
Heartland Food
But what stocks make good choices for ... Keith Speights: I think that Johnson & Johnson (NYSE: JNJ ) checks off all the criteria you would want when buying a stock for your kids. First, J&J is a good business to buy into, with a strong presence in ...
The Motley Fool · ByMatthew Frankel andKeith Speights · 12/7/2014